Share on StockTwits

Analysts’ downgrades for Friday, August 8th:

Alexza Pharmaceuticals (NASDAQ:ALXA) was downgraded by analysts at Roth Capital from a buy rating to a neutral rating.

Braskem SA (NYSE:BAK) was downgraded by analysts at HSBC from an overweight rating to a neutral rating.

Ball (NYSE:BLL) was downgraded by analysts at Citigroup Inc. from a buy rating to a neutral rating.

Bankwell Financial Group (NASDAQ:BWFG) was downgraded by analysts at Keefe, Bruyette & Woods to a market perform rating.

Cambrex Corp. (NYSE:CBM) was downgraded by analysts at First Analysis from an overweight rating to an equal weight rating.

Chipotle Mexican Grill (NYSE:CMG) was downgraded by analysts at Longbow Research from a buy rating to a neutral rating.

Delta Apparel (NYSE:DLA) was downgraded by analysts at Ascendiant Capital Markets from a buy rating to a hold rating.

Henderson Group Plc (LON:HGG) was downgraded by analysts at Citigroup Inc. to a neutral rating. The firm currently has GBX 246 ($4.14) price target on the stock, down from their previous price target of GBX 268 ($4.51).

Hibbett Sports (NASDAQ:HIBB) was downgraded by analysts at BMO Capital Markets from an outperform rating to a market perform rating.

Hibbett Sports (NASDAQ:HIBB) was downgraded by analysts at Credit Suisse from a neutral rating to an underperform rating.

Ignite Restaurant Group (NYSE:IRG) was downgraded by analysts at Raymond James from a market perform rating to an underperform rating.

Laredo Petroleum (NYSE:LPI) was downgraded by analysts at SunTrust from a buy rating to a neutral rating.

Masimo Corp. (NASDAQ:MASI) was downgraded by analysts at Piper Jaffray from an overweight rating to a neutral rating.

Marrone Bio Innovations (NASDAQ:MBII) was downgraded by analysts at Robert W. Baird from an outperform rating to a neutral rating. Robert W. Baird currently has $12.00 target price on the stock, down from their previous target price of $15.00.

Marrone Bio Innovations (NASDAQ:MBII) was downgraded by analysts at Piper Jaffray from an overweight rating to a neutral rating.

Meggitt plc (LON:MGGT) was downgraded by analysts at Canaccord Genuity to a hold rating. Canaccord Genuity currently has GBX 510 ($8.58) target price on the stock, down from their previous target price of GBX 580 ($9.76).

Meggitt plc (LON:MGGT) was downgraded by analysts at Berenberg Bank to a hold rating. They currently have GBX 510 ($8.58) price target on the stock, down from their previous price target of GBX 600 ($10.10).

Mylan (NYSE:MYL) was downgraded by analysts at RBC Capital from an outperform rating to a sector perform rating.

MYR Group (NASDAQ:MYRG) was downgraded by analysts at FBR Capital Markets from an outperform rating to a market perform rating. They currently have $27.00 price target on the stock, down from their previous price target of $30.00.

Ocean Rig UDW (NASDAQ:ORIG) was downgraded by analysts at Nordea Equity Research to a buy rating.

PhotoMedex (NASDAQ:PHMD) was downgraded by analysts at Canaccord Genuity from a buy rating to a hold rating.

Post Holdings (NASDAQ:POST) was downgraded by analysts at SunTrust from a buy rating to a neutral rating.

Rubicon Technology (NASDAQ:RBCN) was downgraded by analysts at Canaccord Genuity from a buy rating to a hold rating. Canaccord Genuity currently has $8.00 target price on the stock, down from their previous target price of $10.00.

Rubicon Technology (NASDAQ:RBCN) was downgraded by analysts at JPMorgan Chase & Co. from an overweight rating to a neutral rating.

Randgold Resources Limited (LON:RRS) was downgraded by analysts at Numis Securities Ltd to an add rating. They currently have GBX 5,800 ($97.59) target price on the stock, down from their previous target price of GBX 5,900 ($99.28).

Stantec (TSE:STN) was downgraded by analysts at National Bank Financial from an outperform rating to a sector perform rating.

Volcano (NASDAQ:VOLC) was downgraded by analysts at Oppenheimer from an outperform rating to a market perform rating. Oppenheimer currently has $15.00 price target on the stock, down from their previous price target of $22.00.

Receive News & Ratings for Alexza Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alexza Pharmaceuticals and related companies with Analyst Ratings Network's FREE daily email newsletter.